Sjs Investment Consulting Inc. Clovis Oncology, Inc. Transaction History

Sjs Investment Consulting Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 13, 2022	SELL	$1.05 - $2.85 $525 - $1,425	-500 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $1,350 - $2,380	500 New	500 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.